Efficacy and Safety of Biosimilar Cetuximab (CETUXA) in Locoregionally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck: A Retrospective Multicenter Analysis.. Journal of Carcinogenesis, [S. l.], v. 24, n. 10s, p. 382–389, 2025. DOI: 10.64149/J.Carcinog.24.10s.382-389. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1662. Acesso em: 26 dec. 2025.